My opinion….
the addressable market for head and neck cancer
pales into insignificance when stood up against
the nsclc market….I just can’t see Merck and immutep
keep funnelling funds into a trial that shows data inconclusive…
Overnight Market report, page-2525
-
- There are more pages in this discussion • 328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.010(2.47%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.5¢ | 41.0¢ | $156.1K | 379.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 183092 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 176067 | 16 |
View Market Depth
| Last trade - 10.40am 13/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |